IGF2 and cancer: Our previous studies showed that Id1-overexpression induces ESCC cells to produce and secrete insulin-like growth factor 2 (IGF2), which stimulates cancer cell proliferation in an autocrine manner14, and that concurrent high Id1 and IGF2 expression in ESCC is associated with shorter survival15.